Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

INTRODUCTION: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare demyelinating disorder of the central nervous system. Despite increased recognition of MOGAD as a distinct disease and the availability of sensitive methods of MOG antibody testing, diagnostic challenges...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Jonathan D., Gould, Jennifer, Panahloo, Zoya, Thompson, Ella, Lefelar, Julia, Palace, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310677/
https://www.ncbi.nlm.nih.gov/pubmed/37024731
http://dx.doi.org/10.1007/s40120-023-00474-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310677/
https://www.ncbi.nlm.nih.gov/pubmed/37024731
http://dx.doi.org/10.1007/s40120-023-00474-9

Ejemplares similares